Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled the release of its fourth quarter and fiscal year 2024 financial results for March 31, 2025, before market opening.

The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Interested participants can dial 877-407-2991 (201-389-0925 for international callers) using access code 13751985. A live webcast will be available on the company's investor relations website, with a two-week replay period available afterward.

03/03/2025 - 04:05 PM

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 financial results will be released before the market opens on Monday, March 31, 2025.

Management will host a conference call at 8:00 a.m. Eastern Time on March 31, 2025 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13751985. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13751985. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

FAQ

When will Venus Concept (VERO) release its Q4 and FY 2024 earnings?

Venus Concept will release its Q4 and FY 2024 earnings before market opens on Monday, March 31, 2025.

How can investors join Venus Concept's (VERO) Q4 2024 earnings call?

Investors can dial 877-407-2991 (201-389-0925 for international) with access code 13751985, or watch the webcast at ir.venusconcept.com at 8:00 a.m. ET on March 31, 2025.

Where can I find the replay of Venus Concept's (VERO) Q4 2024 earnings call?

A two-week replay will be available at 877-660-6853 (201-612-7415 for international) with code 13751985, and the webcast will be archived at ir.venusconcept.com.